Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Oct;38(1):157–161. doi: 10.1128/iai.38.1.157-161.1982

Neutralization of bacteria- and endotoxin-induced hypotension by lipoprotein-free human serum.

A M Abdelnoor, N R Harvie, A G Johnson
PMCID: PMC347711  PMID: 7141687

Abstract

Normal human serum and a fraction rich in lipoprotein, Cohn fraction IV1, have been shown in previous studies to detoxify native endotoxin by decreasing lethality for mice, fever in rabbits, and by the alteration of the characteristic endotoxin-anti-endotoxin precipitin pattern in gels. These studies are extended herein and document the ability of normal human serum and fraction IV1 to neutralize the induction of hypotension in rabbits by viable gram-negative bacilli. Further fractionation of serum, using an ultracentrifugal flotation method for producing lipoprotein-free human serum and purified high-density lipoproteins, revealed the lipoprotein-free fraction to be capable of inhibiting endotoxin hypotensive activity and to alter diffusion of endotoxin in gels. On the other hand, the purified high-density lipoproteins failed to negate either activity.

Full text

PDF
157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdelnoor A. M., Johnson A. G., Anderson-Imbert A., Nowotny A. Immunization against bacteria- and endotoxin-induced hypotension. Infect Immun. 1981 Jun;32(3):1093–1099. doi: 10.1128/iai.32.3.1093-1099.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Freudenberg M. A., Bøg-Hansen T. C., Back U., Galanos C. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun. 1980 May;28(2):373–380. doi: 10.1128/iai.28.2.373-380.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HEGEMANN F. Zur Bedeutung des Blutserums für die Entstehung und das Unwirksamwerden bakterieller Reizstoffe beim Menschen. II. Die neutralisierende Wirkung des menschlichen Serums auf das Endotoxin von Colibakterien. Z Immun exp ther. 1954 Aug;111(3):213–225. [PubMed] [Google Scholar]
  4. Harvie N. R., Schultz J. S. Studies of Lp-lipoprotein as a quantitative genetic trait. Proc Natl Acad Sci U S A. 1970 May;66(1):99–103. doi: 10.1073/pnas.66.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Johnson K. J., Ward P. A., Goralnick S., Osborn M. J. Isolation from human serum of an inactivator of bacterial lipopolysaccharide. Am J Pathol. 1977 Sep;88(3):559–574. [PMC free article] [PubMed] [Google Scholar]
  6. LANDY M. Enhancement of the immunogenicity of typhoid vaccine by retention of the V1 antigen. Am J Hyg. 1953 Sep;58(2):148–164. doi: 10.1093/oxfordjournals.aje.a119596. [DOI] [PubMed] [Google Scholar]
  7. LEVER W. F., GURD F. R. N., UROMA E., BROWN R. K., BARNES B. A., SCHMID K., SCHULTZ E. L. Chemical, clinical and immunological studies on the products of human plasma fractionation XL. Quantitative separation and determination of the protein components in small amounts of normal human plasma. J Clin Invest. 1951 Jan;30(1):99–111. doi: 10.1172/JCI102423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Maier R. V., Mathison J. C., Ulevitch R. J. Interactions of bacterial lipopolysaccharides with tissue macrophages and plasma lipoproteins. Prog Clin Biol Res. 1981;62:133–155. [PubMed] [Google Scholar]
  9. Munford R. S., Hall C. L., Dietschy J. M. Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins. Infect Immun. 1981 Dec;34(3):835–843. doi: 10.1128/iai.34.3.835-843.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. RALL D. P., GASKINS J. R., KELLY M. G. Reduction of febrile response to bacterial polysaccharide following incubation with serum. Am J Physiol. 1957 Mar;188(3):559–562. doi: 10.1152/ajplegacy.1957.188.3.559. [DOI] [PubMed] [Google Scholar]
  11. RUDBACH J. A., JOHNSON A. G. Changes in serologic reactivity of endotoxin induced by fraction IV-1 (Cohn) of normal human serum. Proc Soc Exp Biol Med. 1962 Dec;111:651–655. doi: 10.3181/00379727-111-27882. [DOI] [PubMed] [Google Scholar]
  12. RUDBACH J. A., JOHNSON A. G. RESTORATION OF ENDOTOXIN ACTIVITY FOLLOWING ALTERATION BY PLASMA. Nature. 1964 May 23;202:811–812. doi: 10.1038/202811a0. [DOI] [PubMed] [Google Scholar]
  13. Rudbach J. A., Anacker R. L., Haskins W. T., Johnson A. G., Milner K. C., Ribi E. Physical aspects of reversible inactivation of endotoxin. Ann N Y Acad Sci. 1966 Jun 30;133(2):629–643. doi: 10.1111/j.1749-6632.1966.tb52394.x. [DOI] [PubMed] [Google Scholar]
  14. Rudbach J. A., Johnson A. G. Alteration and restoration of endotoxin activity after complexing with plasma proteins. J Bacteriol. 1966 Oct;92(4):892–898. doi: 10.1128/jb.92.4.892-898.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SKARNES R. C., ROSEN F. S., SHEAR M. J., LANDY M. Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma. J Exp Med. 1958 Nov 1;108(5):685–699. doi: 10.1084/jem.108.5.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Skarnes R. C. Host defense against bacterial endotoxemia: mechanism in normal animals. J Exp Med. 1970 Aug 1;132(2):300–316. doi: 10.1084/jem.132.2.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Skarnes R. C. In vivo interaction of endotoxin with a plasma lipoprotein having esterase activity. J Bacteriol. 1968 Jun;95(6):2031–2034. doi: 10.1128/jb.95.6.2031-2034.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ulevitch R. J., Johnston A. R. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. J Clin Invest. 1978 Dec;62(6):1313–1324. doi: 10.1172/JCI109252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ulevitch R. J., Johnston A. R., Weinstein D. B. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest. 1979 Nov;64(5):1516–1524. doi: 10.1172/JCI109610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. YOSHIOKA M., JOHNSON A. G. Characteristics of endotoxin altering fractions derived from normal human serum. J Immunol. 1962 Sep;89:326–335. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES